A publisher makes an error in a publication about errors

Jennifer Byrne

Publishing a research paper is usually cause for celebration, after what is typically years of effort. Our recent paper in which we found that unexpectedly high proportions of papers in two journals described at least one wrongly identified reagent should have been no exception.

But alas. Any of our celebrations have been tempered by Springer Nature’s bizarre introduction of an unrelated figure into the paper. Here’s what has happened so far.

Continue reading A publisher makes an error in a publication about errors

Publisher error claims joke paper, April Fools’ tradition – three years later

A journal says a content management mishap led to the publication, and subsequent retraction, of a gag essay not intended for wide distribution. 

Why the retraction happened three and a half years after the paper’s publication remains murky.

This story belongs to the early days of the COVID-19 pandemic, back when Proteins: Structure, Function, and Bioinformatics, a Wiley title, used to gather spoof papers for its annual April Fools edition.  

As Kristofer Barr, an assistant research integrity auditor at Wiley, told us: 

Continue reading Publisher error claims joke paper, April Fools’ tradition – three years later

Three journals’ web domains expired. Then major indexes pointed to hijacked versions

Anna Abalkina

Have you heard about hijacked journals, which take over legitimate publications’ titles, ISSNs, and other metadata without their permission? We recently launched the Retraction Watch Hijacked Journal Checker, and will be publishing regular posts like this one to tell the stories of some of those cases. 

When web domains of legitimate journals expire, fraudulent publishers have an opening to hijack them by registering the expired domains and creating clone websites that mimic the genuine journal.  

In 2015, John Bohannon found fraudulent publishers had hijacked the websites of several legitimate journals indexed in Web of Science. The expired domains of GMP Review and Ludus Vitalis, which Web of Science listed as their official homepages, were registered by the fraudulent publishers, who created clone journals offering to publish papers for a fee. 

Taking over expired domains remains a successful strategy for fraudulent publishers, because potential authors may use the websites listed in scientometric databases to verify the authenticity of a journal. Recently, three examples have come to light of journals with domains that expired and were hijacked by fake journals.

Continue reading Three journals’ web domains expired. Then major indexes pointed to hijacked versions

Elsevier journal temporarily removes article by prolific psychologist – with a typo at “frist”

An Elsevier psychology journal took down an article in early December with a notice that appeared to be an internal memo, including a typo. 

The article, a letter titled “First COVID-19 suicide case in Bangladesh due to fear of COVID-19 and xenophobia: Possible suicide prevention strategies,” was published in June of 2020 in the Asian Journal of Psychiatry by Mark D. Griffiths of Nottingham Trent University in the UK and Mohammed A. Mamun of Jahangirnagar University and the Undergraduate Research Organization in Dhaka, Bangladesh. It has been cited more than 300 times, according to Clarivate’s Web of Science. 

Griffiths’ high publishing rate – according to his university’s index he published nearly 200 journal articles in 2022 – came under scrutiny from Oxford University psychologist Dorothy Bishop in 2020, including his many collaborations with Mamun. Griffiths told the Times Higher Education that he “made an intellectual contribution to every refereed paper I’ve published.” 

Continue reading Elsevier journal temporarily removes article by prolific psychologist – with a typo at “frist”

‘Inadvertently published’ paper by pharma employee retracted almost a year later

A Takeda employee has lost a 2021 paper that the journal says it “inadvertently published.”  

The article, “Seasonal and Secular Periodicities Identified in the Dynamics of US FDA Medical Devices (1976–2020): Portends Intrinsic Industrial Transformation and Independence of Certain Crises,” appeared in Therapeutic Innovation & Regulatory Science. It has yet to be cited, according to Clarivate Analytics’ Web of Science 

The retraction notice from a few days ago says, in full: 

Continue reading ‘Inadvertently published’ paper by pharma employee retracted almost a year later

Journal retracts a paper, then publishes it in an issue 11 months later

The article as it appears at the time of this writing

Yes, you read that headline right.

In January 2021, we reported that The Journal of Strength and Conditioning Research (JSCR) would soon be retracting two papers because a graduate student had committed misconduct in the work.

The journal – the official research publication of the National Strength and Conditioning Association (NCSA) – did retract the papers, according to a notice posted to PubMed and on the title’s site, both dated March 2021.

But that didn’t stop one of the articles – which had first gone online in December 2019 – from appearing in the February 2022 issue of the journal, without any indication it had been retracted, as Universidad Autónoma de Madrid professor Carlos Balsalobre noticed yesterday:

Continue reading Journal retracts a paper, then publishes it in an issue 11 months later

Wiley snafu costs an early-stage researcher his first paper

Through no fault of his own, Martin Bordewieck is oh-for-one in his publishing career. 

The psychology researcher at Ruhr-University Bochum, in Germany, published his very first paper in Applied Cognitive Psychology in August 2020 – only to lose the article to retraction because of a screw-up by the journal. 

Malte Elson, Bordewieck’s co-author – whose name might be familiar to readers of Retraction Watch for his work as a data sleuth – called the situation “a weird one”: 

Continue reading Wiley snafu costs an early-stage researcher his first paper

A correction is retracted (sort of)

Thanks to a publisher’s error, a group of infectious disease researchers has experienced a double negative for their 2020 article on tick-borne illness in South Africa. 

The paper, “Serum-free in vitro cultivation of Theileria annulata and Theileria parva schizont-infected lymphocytes,” appeared in Transboundary and Emerging Diseases, a Wiley title. The authors were affiliated with institutions in Europe, Africa, the Middle East and the United States. 

Earlier this year, the authors corrected their article. The notice, dated May 26, reads

Continue reading A correction is retracted (sort of)

Elsevier corrects a retraction notice following questions from Retraction Watch

An Elsevier journal has corrected a retraction notice after we asked questions about what exactly it was saying — but not before the journal’s editor tried to defend what turned out to be a mistaken passage.

The article, “Measurement of performance parameters and improvement in optimized solution of WEDM on a novel titanium hybrid composite,” was published online in Measurement in December 2020. The retraction notice, which appeared online on September 17 of this year, read:

Continue reading Elsevier corrects a retraction notice following questions from Retraction Watch

Elsevier glitch prompts temporary removal of critique of review on race and heart disease

A timing glitch prompted the temporary removal of a letter to the editor calling out a previously published study for “perpetuating historical harms” through its framing of race and ethnicity. 

The letter, “Race is not a risk factor: Reframing discourse on racial health inequities in CVD prevention,” appeared online in April in the American Journal of Preventive Cardiology, an Elseiver property. It came in response to a review article, published the month before, titled “Ten things to know about ten cardiovascular disease risk factors.”

As the abstract of the review stated: 

Continue reading Elsevier glitch prompts temporary removal of critique of review on race and heart disease